skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8847

Competing interests in development of clinical practice guidelines for diabetes management: Report from a multidisciplinary workshop

Original Research

(2925) Views  (607) Full article downloads

Authors: Anna M Sawka, Lilian Magalhães, Amiram Gafni, Gary F Lewis

Published Date May 2008 Volume 2008:1 Pages 29 - 34
DOI: http://dx.doi.org/10.2147/JMDH.S3553

Anna M Sawka1, Lilian Magalhães2, Amiram Gafni3,4, Gary F Lewis1

1Division of Endocrinology, Department of Medicine, University Health Network and University of Toronto, Toronto, Ontario, Canada; 2School of Occupational Therapy, University of Western Ontario, London, Ontario, Canada; 3Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada; 4Centre for Health Economics and Policy Analysis, Hamilton, Ontario, Canada

Objective: To explore the complex issue of competing interests (CIs) in development of clinical practice guidelines (CPGs) in diabetes with stakeholders.

Methods: A multidisciplinary panel of 26 health, methodological, legal, and bioethical experts, trainees, and lay people from across Canada participated in a workshop on CIs in CPGs. Mixed methods were used such that qualitative themes were extracted from the discussions and quantitative survey data were collected.

Results: In the discussions, participants acknowledged that potential competing interests were not uncommon among sponsoring organizations and authors of CPGs. Avoidance of all potential CIs in development of CPGs was emulated as ideal, but considered probably unrealistic, given the paucity of peer-reviewed funding opportunities for development of evidence-informed CPGs and the scarcity of knowledgeable authors without CIs. An optimal approach for management of CIs in CPGs could not be agreed upon by participants. Full disclosure of any financial CIs for authors and sponsoring organizations as well as discouragement of external financial contributors from writing involvement, were endorsed by participants in the workshop and a subsequent survey.

Conclusions: Complete disclosure of financial CIs of sponsoring organizations and authors of CPGs is essential, yet the optimal approach to management of potential CIs is currently undefined.

Keywords: conflicts of interest, clinical practice guidelines, diabetes, knowledge translation, bioethics








Readers of this article also read:

Measuring health outcomes of a multidisciplinary care approach in individuals with chronic environmental conditions using an abbreviated symptoms questionnaire
Age- and sex-related regional compressive strength characteristics of human lumbar vertebrae in osteoporosis
Long-term sick-leavers with fibromyalgia: Comparing their multidisciplinarily assessed characteristics with those  of others with chronic pain conditions and depression
Maximally efficient two-stage screening: Determining intellectual disability in Taiwanese military conscripts
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Exacerbation rate, health status and mortality in COPD – a review of potential interventions
Health literacy and health seeking behavior among older men in a middle-income nation
A case of recurrent bloody tears
Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy
Erratum
  • Testimonials

    "You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio